0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R2,500 - R5,000 (2)
  • R5,000 - R10,000 (4)
  • -
Status
Brand

Showing 1 - 6 of 6 matches in All Departments

Biological and Hormonal Therapies of Cancer (Hardcover, 1998 ed.): Kenneth A. Foon, Hyman B. Muss Biological and Hormonal Therapies of Cancer (Hardcover, 1998 ed.)
Kenneth A. Foon, Hyman B. Muss
R8,454 Discovery Miles 84 540 Ships in 10 - 15 working days

This volume, Biological and Hormonal Therapies of Cancer, which is part of the series Cancer Treatment and Research, presents selected new information concerning biologic and hormonal therapy of cancer. We have attempted to provide the reader with topics of major interest in a timely fashion. There is renewed interest in biologic therapy of cancer. Two chapters review the role of interferon in the hematologic malignancies and in solid tumors. Vaccine therapies have come to the forefront of cancer therapy re cently, and two chapters approach different strategies of vaccine therapies; one reviews the cellular vaccine therapies and another the anti-idiotype ap proach. The hormonal therapy chapters focus on current uses of endocrine therapy in endometrial, breast, and prostate cancer. In addition, hormonal strategies for the prevention of breast cancer and endometrial cancer, including excit ing information relating to phytochemicals, are presented. The effects of tamoxifen on endometrium is a topic of major interest and is discussed in detail. Finally, there is a chapter on estrogen receptor expression and regula tion in human breast cancer. These chapters are all written by experts in the field and contain timely and relevant information of interest to laboratory and clinical scientists and practitioners alike. Biologic and endocrine therapies represent major areas of cancer research interest. The advent of newer biologic therapies, including new antibody targeted treatments, and the use of biologics as tumor modulators to enhance the effects of other treatment regimens is an exploding avenue of research."

Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias (Hardcover, 1988 ed.): John M. Bennett,... Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias (Hardcover, 1988 ed.)
John M. Bennett, Kenneth A. Foon
R5,754 Discovery Miles 57 540 Ships in 10 - 15 working days

Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general on cology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good indepth reviews of cancer topics, and published symposium lectures are often the best overviews available. Un fortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by dividing the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more."

Monoclonal Antibody Therapy of Human Cancer (Hardcover, 1985 ed.): Kenneth A. Foon, Alton C. Morgan Monoclonal Antibody Therapy of Human Cancer (Hardcover, 1985 ed.)
Kenneth A. Foon, Alton C. Morgan
R2,973 Discovery Miles 29 730 Ships in 10 - 15 working days

KENNETH A. FOON and ALTON C. MORGAN, JR. Passive immunotherapy using heteroantisera for the treatment of cancer in animals and humans has been studied for over 50 years. Attempts have been made to treat animal tumors with sera from immunized syngeneic, allogeneic, or xenogeneic animals. A number of studies of passive immunotherapy using heterologous antisera in humans have also been performed. These studies have generally been attempted in patients with large tumor burdens, and as would be expected, results have been transient at best. A wide variety of solid tumors as well as leukemias and lym- phomas have been treated with antisera raised in sheep, horses, rabbits, and goats. Problems such as anaphylaxis, serum sick- ness, and severe cytopenias have been encountered with these antisera. There are a number of potential mechanisms by which unconju- gated antibodies might be cytotoxic to tumor cells. Antibodies bound to the cell surface membrane of tumor cells may lead to cell lysis by complement-dependent or antibody-dependent cellu- lar cytotoxicity. Circulating tumor cells bound by antibody may be more susceptible to phagocytosis by the reticuloendothelial system. Antibody bound to the cell surface membrane of tumor cells may enhance immunogenicity of the tumor cell leading to activation of the host's immune system.

Biological and Hormonal Therapies of Cancer (Paperback, Softcover reprint of the original 1st ed. 1998): Kenneth A. Foon, Hyman... Biological and Hormonal Therapies of Cancer (Paperback, Softcover reprint of the original 1st ed. 1998)
Kenneth A. Foon, Hyman B. Muss
R8,284 Discovery Miles 82 840 Ships in 10 - 15 working days

This volume, Biological and Hormonal Therapies of Cancer, which is part of the series Cancer Treatment and Research, presents selected new information concerning biologic and hormonal therapy of cancer. We have attempted to provide the reader with topics of major interest in a timely fashion. There is renewed interest in biologic therapy of cancer. Two chapters review the role of interferon in the hematologic malignancies and in solid tumors. Vaccine therapies have come to the forefront of cancer therapy re cently, and two chapters approach different strategies of vaccine therapies; one reviews the cellular vaccine therapies and another the anti-idiotype ap proach. The hormonal therapy chapters focus on current uses of endocrine therapy in endometrial, breast, and prostate cancer. In addition, hormonal strategies for the prevention of breast cancer and endometrial cancer, including excit ing information relating to phytochemicals, are presented. The effects of tamoxifen on endometrium is a topic of major interest and is discussed in detail. Finally, there is a chapter on estrogen receptor expression and regula tion in human breast cancer. These chapters are all written by experts in the field and contain timely and relevant information of interest to laboratory and clinical scientists and practitioners alike. Biologic and endocrine therapies represent major areas of cancer research interest. The advent of newer biologic therapies, including new antibody targeted treatments, and the use of biologics as tumor modulators to enhance the effects of other treatment regimens is an exploding avenue of research.

Monoclonal Antibody Therapy of Human Cancer (Paperback, Softcover reprint of the original 1st ed. 1985): Kenneth A. Foon, Alton... Monoclonal Antibody Therapy of Human Cancer (Paperback, Softcover reprint of the original 1st ed. 1985)
Kenneth A. Foon, Alton C. Morgan
R2,840 Discovery Miles 28 400 Ships in 10 - 15 working days

KENNETH A. FOON and ALTON C. MORGAN, JR. Passive immunotherapy using heteroantisera for the treatment of cancer in animals and humans has been studied for over 50 years. Attempts have been made to treat animal tumors with sera from immunized syngeneic, allogeneic, or xenogeneic animals. A number of studies of passive immunotherapy using heterologous antisera in humans have also been performed. These studies have generally been attempted in patients with large tumor burdens, and as would be expected, results have been transient at best. A wide variety of solid tumors as well as leukemias and lym- phomas have been treated with antisera raised in sheep, horses, rabbits, and goats. Problems such as anaphylaxis, serum sick- ness, and severe cytopenias have been encountered with these antisera. There are a number of potential mechanisms by which unconju- gated antibodies might be cytotoxic to tumor cells. Antibodies bound to the cell surface membrane of tumor cells may lead to cell lysis by complement-dependent or antibody-dependent cellu- lar cytotoxicity. Circulating tumor cells bound by antibody may be more susceptible to phagocytosis by the reticuloendothelial system. Antibody bound to the cell surface membrane of tumor cells may enhance immunogenicity of the tumor cell leading to activation of the host's immune system.

Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias (Paperback, Softcover reprint of the... Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias (Paperback, Softcover reprint of the original 1st ed. 1988)
John M. Bennett, Kenneth A. Foon
R5,581 Discovery Miles 55 810 Ships in 10 - 15 working days

Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general on cology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good indepth reviews of cancer topics, and published symposium lectures are often the best overviews available. Un fortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by dividing the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more."

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Violence, Narrative and Myth in Joyce…
T. Balinisteanu Hardcover R1,953 Discovery Miles 19 530
Jane Austen
Henrietta Heald Hardcover  (1)
R306 R229 Discovery Miles 2 290
Victorian Literary Cultures - Studies in…
Kenneth Womack, James M. Decker Hardcover R2,129 Discovery Miles 21 290
Mazes For Clever Kids Buster Brain Games
Dr Gareth Moore Paperback R139 Discovery Miles 1 390
Paper Liberals - Press and Politics in…
David Ortiz Hardcover R2,752 Discovery Miles 27 520
Excursions with Thoreau - Philosophy…
Edward F. Mooney Hardcover R4,922 Discovery Miles 49 220
Browning Upon Arabia - A Moveable East
Hedi A. Jaouad Hardcover R2,739 Discovery Miles 27 390
The History of Contemporary Italy…
Umberto Gentiloni Silveri Hardcover R3,903 Discovery Miles 39 030
De Quincey's Disciplines
Josephine McDonagh Hardcover R4,166 Discovery Miles 41 660
Parcel Of Death - The Biography Of…
Gaongalelwe Tiro Paperback R310 R281 Discovery Miles 2 810

 

Partners